CSBR - Champions Oncology - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CSBR is currently covered by 1 analysts with an average price target of $8.32. This is a potential upside of $2.1 (33.76%) from yesterday's end of day stock price of $6.22.

Champions Oncology's activity chart (see below) currently has 3 price targets and 4 ratings on display. The stock rating distribution of CSBR is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 66.67% with an average time for these price targets to be met of 281 days.

Highest price target for CSBR is $5, Lowest price target is $5, average price target is $7.5.

Most recent stock forecast was given by SCOTT HENRY from ROTH on 22-Sep-2023. First documented stock forecast 20-Sep-2019.

Best performing analysts who are covering CSBR - Champions Oncology:

Scott Henry

Currently out of the existing stock ratings of CSBR, 1 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$7.5

$1.28 (20.58%)

$16

1 years 7 months 19 days ago
(22-Sep-2023)

2/3 (66.67%)

$2.1 (38.89%)

281

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CSBR (Champions Oncology) average time for price targets to be met?

On average it took 281 days on average for the stock forecasts to be realized with a an average price target met ratio 66.67

Which analyst has the current highest performing score on CSBR (Champions Oncology) with a proven track record?

SCOTT HENRY

Which analyst has the most public recommendations on CSBR (Champions Oncology)?

Scott Henry works at ALLIANCE GLOBAL PARTNERS and has 7 price targets and 4 ratings on CSBR

Which analyst is the currently most bullish on CSBR (Champions Oncology)?

Scott Henry with highest potential upside - $1.28

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?